Kaleida Health

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

Retrieved on: 
Wednesday, January 24, 2024
Assistant, Patient, Laser, Neurosurgery, Medical director, University, Spine, Kaleida Health, Paper, Brain, Medical device

SOLANA BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System by Dr. Jonathan Riley and team at Kaleida Health in Buffalo, New York.

Key Points: 
  • SOLANA BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System by Dr. Jonathan Riley and team at Kaleida Health in Buffalo, New York.
  • “We are ecstatic to have completed our first successful case with combined ClearPoint Neuro MRI targeting and laser ablation solutions,” stated Dr. Jonathan Riley, Assistant Professor of Neurosurgery at the University of Buffalo, and Medical Director of Functional Neurosurgery at Kaleida Health.
  • We look forward to continued success together with the team at Kaleida Health and as we look to expand into full market release later this year.”
    The ClearPoint Prism Neuro Laser Therapy System features the only non-cooled laser applicator on the market.
  • For more information about the ClearPoint Neuro Laser Therapy System please visit: https://www.clearpointneuro.com/clearpoint-prism-neuro-laser-system/

Davis Polk Welcomes William J. Hochul, Jr. in New York

Retrieved on: 
Tuesday, January 2, 2024
Legal, Professional Services, Delaware North, Davis Polk, Government, Justice, Terrorism, Partnership, Law, Buffalo Six, Lawyer, University, Corruption, General counsel, AUSA, Public service, Kaleida Health, Offense, History, Nursing

“We are delighted to welcome Bill to the Firm,” said Neil Barr, Davis Polk’s Managing Partner.

Key Points: 
  • “We are delighted to welcome Bill to the Firm,” said Neil Barr, Davis Polk’s Managing Partner.
  • Mr. Hochul most recently served, from November 2016 until August 2023, as Senior Vice President, General Counsel and Secretary of Delaware North Companies, the multinational food service, gaming and hospitality company headquartered in Buffalo, New York.
  • Prior to that role, Mr. Hochul served for nearly 30 years in various roles at the U.S. Department of Justice.
  • From 1991 until 2010, Mr. Hochul served as an Assistant U.S. Attorney in the Western District of New York.

LeanTaaS Announces Sixth Transform Hospital Operations Virtual Summit in Partnership with Becker’s Healthcare

Retrieved on: 
Tuesday, November 21, 2023
Technology, Hospitals, Health Technology, Software, Practice Management, Biotechnology, Managed Care, Health, Data Management, Artificial Intelligence, Operating, Organization, Transform, Bed, UCHealth, Public expenditure, Kaleida Health, Machine learning, Automation, University, Partnership, Software as a service, Mayo Clinic, Environment, Hospital, AI, Baptist Health, Innovation system, Management

Hosted in partnership with Becker’s Healthcare , the sixth Transform Hospital Operations Virtual Summit will take place Dec. 5-6, 2023 and will offer attendees a dedicated event for infusion center leaders, Transform Infusion Center Operations Virtual Summit , on day two.

Key Points: 
  • Hosted in partnership with Becker’s Healthcare , the sixth Transform Hospital Operations Virtual Summit will take place Dec. 5-6, 2023 and will offer attendees a dedicated event for infusion center leaders, Transform Infusion Center Operations Virtual Summit , on day two.
  • We’re very excited to be hosting our sixth Transform Hospital Operations Summit to showcase so many forward-thinking healthcare leaders who are achieving incredible outcomes and helping short-staffed teams do their jobs better.”
    The two-day Transform Hospital Operations Summit features thought leadership sessions on mastering and deploying disruptive technologies, as well as dedicated perioperative and inpatient flow tracks.
  • To register and learn more about the sessions and speakers that will be featured at the Transform Hospital Operations Virtual Summit, view the conference agenda here .
  • To learn more about how infusion center operations can be transformed with AI, visit the Transform Infusion Center Operations Virtual Summit agenda here .

Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy

Retrieved on: 
Friday, November 10, 2023
Health, Medical Devices, General Health, Radiology, Clinical Trials, Cardiology, Biotechnology, Medicine, Arm, Food and Drug Administration, Disease, DRS, Hypertension, Food, M.B.B.S, RDN, Physician, Structural heart disease, Surgeon, Mortality, Cardiovascular disease, TRIO, Cleveland Clinic, Multimedia, Patient, Renal artery, Kaleida Health, Division, FDA, Master of Science, Gates Vascular Institute, Intervention, Biomedical sciences, University, MD, Doctor of Philosophy, Hospital, NewYork-Presbyterian Hospital, Blood pressure, Medical imaging, Pharmaceutical industry, Buffalo, Paradise

Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation (uRDN) system for the treatment of hypertension, the first FDA approved renal denervation therapy in the United States.

Key Points: 
  • Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation (uRDN) system for the treatment of hypertension, the first FDA approved renal denervation therapy in the United States.
  • The first commercial procedures took place at NewYork-Presbyterian/Columbia University Irving Medical Center in New York City by Drs.
  • Paradise uRDN delivers two to three doses of 360-degree ultrasound energy — lasting seven seconds each — through the main renal arteries to the surrounding nerves.
  • “This new renal denervation technology for a high-risk patient population – individuals with difficult to control hypertension – has been long awaited.

Dental Care Alliance Proudly Announces the Opening of a De Novo Practice, Alliance Dental Care, in East Longmeadow, MA

Retrieved on: 
Thursday, August 10, 2023
Dentistry, Human, Bachelor of Science, Dental care, Education, Life, DCA, Dental implant, State university system, University at Buffalo, Buffalo, Family medicine, Dental surgery, Dentist, Patient, Pace University, Love, DDS, Growth, Hospital, Environment, Family, Kaleida Health, Soft drink

SARASOTA, Fla., Aug. 10, 2023 /PRNewswire-PRWeb/ -- Dental Care Alliance announces the opening of a de novo practice, Alliance Dental Care, in East Longmeadow, MA. The brand new state-of-the-art de novo practice, led by Dr. Vinay Kapoor, opened its doors on July 17, 2023.

Key Points: 
  • Dental Care Alliance announces the opening of a de novo practice, Alliance Dental Care, in East Longmeadow, MA.
  • SARASOTA, Fla., Aug. 10, 2023 /PRNewswire-PRWeb/ -- Dental Care Alliance announces the opening of a de novo practice, Alliance Dental Care, in East Longmeadow, MA.
  • With a warm and welcoming environment, patient centric approach to care, and the multitude of services offered, Alliance Dental Care is truly a one-stop dental care center that puts patients first.
  • "Here at Alliance Dental Care, we provide dental services in a compassionate, fun and professional environment," shared Dr. Kapoor.

NORTHEAST GROCERY COMPLETES ITS EXECUTIVE TEAM WITH PROMOTION OF JOHN PERSONS TO CHIEF OPERATING OFFICER

Retrieved on: 
Thursday, June 29, 2023
Learning, Price, Human resources, Operation, Kaleida Health, University, Senior, Information technology, Marketing, Service, Curci, Parent, Risk management, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, Buffalo, History, Both, Houghton University, CAO, Oklahoma Secretary of Human Resources and Administration, Administration, NGI, Northeast Grocery, Tops Friendly Markets, CFO, Growth, CIO, Hospital, Region, Management, Person, Tops

SCHENECTADY N.Y. and WILLIAMSVILLE, N.Y., June 29, 2023 /PRNewswire/ -- Northeast Grocery, Inc. (NGI), the parent company of Price Chopper/Market 32 and Tops Friendly Markets, has named John Persons as Chief Operating Officer. Persons will oversee both the Price Chopper/Market 32 and Tops Markets operating companies, as well as the Northeast Shared Services (a subsidiary of NGI providing services to both operating companies) merchandising and marketing functions. He will report directly to Frank Curci, CEO of Northeast Grocery, Inc. Ron Ferri, a 34-year Tops veteran, will succeed Persons as Tops president.

Key Points: 
  • He will report directly to Frank Curci, CEO of Northeast Grocery, Inc. Ron Ferri, a 34-year Tops veteran, will succeed Persons as Tops president.
  • In addition to Persons' promotion, Mike Miller has been named Chief Administrative Officer (CAO).
  • Miller was previously Senior Vice President, Human Resources and Executive Vice President, Human Resources and Administration at Northeast Shared Services.
  • Ferri, previously Executive Vice President, Operations & Distribution at Tops, has been promoted to president of Tops and will also report to Persons.

Vivasure Medical Announces Enrollment of First Patients in Pivotal PATCH Study

Retrieved on: 
Tuesday, May 2, 2023
Cardiology, Biotechnology, Health, General Health, Pharmaceutical, Health Technology, Medical Devices, Research, Hospitals, Science, Clinical Trials, Kaleida Health, University, University at Buffalo Law School, Stenosis, Main Line Health, Cardiovascular disease, Trial of the century, CAD, TEVAR, Patient, TAVR, Hospital, EVAR, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Aortic stenosis, Food, Safety, Pharmaceutical industry, Medical device, Buffalo

Vivasure Medical® , a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the first patients in the company’s PerQseal® PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal Closure Device System.

Key Points: 
  • Vivasure Medical® , a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the first patients in the company’s PerQseal® PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal Closure Device System.
  • The current approach to large-diameter arterial closure is a surgical repair or the use of suture- or collagen-based closure devices.
  • “I’m honored to participate in this study and look forward to gathering additional clinical evidence supporting this innovation’s potential benefits.”
    Vivasure’s pivotal study will enroll up to 171 patients across the U.S. and up to 90 patients in up to eight European investigational sites.
  • The data will support a pre-market approval submission to the U.S. Food and Drug Administration (FDA).

Synchron to Begin Patient Enrollment for the COMMAND Trial of Brain-Computer Interface at Gates Vascular Institute

Retrieved on: 
Monday, March 20, 2023
Hardware, FDA, Health Technology, Technology, Nanotechnology, Surgery, Medical Devices, Neurology, Clinical Trials, Biotechnology, Science, Software, Other Science, Research, Health, Mobile, Wireless, Extremities, UB, Kaleida Health, University, Gates Vascular Institute, BCI, Jacobs School of Medicine and Biomedical Sciences, COMMAND, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, MBA, Brain, Biomedical sciences, CMO, Doctor of Philosophy, Computer, Jacobs Institute for Design Innovation, Trial of the century, Paralysis, Blood, Motor cortex, University of Pittsburgh Medical Center, Professor, MD, FAHA, Patient, Physician, SUNY, FACS, SUNY UB, EFS, IDE, Mount Sinai Health System, JAMA Neurology, Safety, Medical imaging, Medical device, Management, Medicine, Beckman Coulter, Neurosurgery

The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.

Key Points: 
  • The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.
  • The new site at Gates Vascular Institute marks the third approved COMMAND trial location, joining Mount Sinai Health System in New York and the University of Pittsburgh Medical Center.
  • The FDA granted Breakthrough Device designation to Synchron in August 2020 and an IDE in July 2021.
  • There is no guarantee of participation and principal investigators make the final determination of patient eligibility.

NovaSignal Donates NovaGuide™ 2 Intelligent Ultrasound to The Jacobs Institute to Advance Stroke Research

Retrieved on: 
Tuesday, February 28, 2023
Jacobs, Embolism, MD, CMO, Cerebral infarction, Risk, Brain, Research, Gates Vascular Institute, Algorithm, Patient, TCD, Jacobs Institute for Design Innovation, Jacobs School of Medicine and Biomedical Sciences, Doctor of Philosophy, United, Kaleida Health, Robotics, Vascular disease, Stroke, Medical imaging, Buffalo

A non-profit vascular medical technology innovation center, the Jacobs Institute operates at the forefront of developing the next generation of medical technology for the treatment of vascular disease.

Key Points: 
  • A non-profit vascular medical technology innovation center, the Jacobs Institute operates at the forefront of developing the next generation of medical technology for the treatment of vascular disease.
  • The robotic NovaGuide 2 Intelligent Ultrasound makes it easier for healthcare professionals to monitor patients during medical procedures.
  • “Vascular disease research continues to evolve and advance because of companies like NovaSignal,” said Adnan H. Siddiqui, MD, Ph.D., CEO/CMO of the Jacobs Institute and Director of Neurosurgical Stroke Service for Kaleida Health.
  • “We’re honored to receive this donation and to continue the important research about stroke related events following cardiac procedures.

Servotronics, Inc. Appoints New Human Resources Director

Retrieved on: 
Monday, February 20, 2023
Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, Organization, Master of Business Administration, General Motors, ATG, Human resources, CPG, NYSE, State university system, Dresser-Rand, SVT, Canisius College, NYSE American, Business administration, Buffalo, Kaleida Health, Growth, Management, Servotron

ELMA, N.Y., Feb. 20, 2023 /PRNewswire/ -- Servotronics, Inc. (NYSE American – SVT), a designer and manufacturer of servo-control components and other advanced technology products, today announced that it has appointed Carrie Czerwinski as Director of Human Resources.

Key Points: 
  • ELMA, N.Y., Feb. 20, 2023 /PRNewswire/ -- Servotronics, Inc. (NYSE American – SVT), a designer and manufacturer of servo-control components and other advanced technology products, today announced that it has appointed Carrie Czerwinski as Director of Human Resources.
  • "We are pleased to welcome Carrie Czerwinski as our new Director of Human Resources, bringing a wealth of experience in managing and developing talent across all levels in a range of organizations.
  • Ms. Czerwinski will be responsible for overseeing all human resources functions for Servotronics' Advanced Technology Group (ATG) and the Consumer Products Group (CPG) as well as the corporate group.
  • I am excited to bring my experience to the Company and work closely with the leadership team to enhance our human resources practices to drive long-term growth in each area of our business," said Carrie Czerwinski, Director of Human Resources.